Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.00    1.80 (1.74%)
Bid:
103.80
Ask:
105.00
Spread: 1.20 (1.156%)
Market Cap: £172.14m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Trading update

11 Jul 2014 07:00

RNS Number : 0240M
Synthomer PLC
11 July 2014
 



11th July 2014

 

Synthomer plc

 

Trading update

 

Synthomer plc ("Synthomer" or the "Group") today issues a trading update ahead of its interim results on 11th August 2014.

 

The Group has continued to see similar trends to those seen during the first quarter of the year which it highlighted at the time of its Interim Management Statement on 1 May 2014.

 

In Europe and North America, trading has continued in line with the first quarter of the year and our expectations. Volumes were ahead of the prior year in our Construction & Coatings, Functional Polymers and Performance Polymers segments, whilst average cash margins in the second quarter have remained similar to the first three months of 2014.

 

In Asia and Rest of the World, the strong competition between glove manufacturers that we reported at the time of our Q1 IMS in May has continued. This has caused ongoing margin pressure in our Nitrile business, exacerbated by weak Butadiene pricing and a related period of customer de-stocking. This prolonged pressure means that operating profit for the first half of the year for Asia will be approximately £4m below our first half performance in 2013 (H1 2013: £11.5m). However, as the second half progresses we continue to expect demand for nitrile latex to grow and unit margins to firm.

 

In addition, sterling strengthened further during the period. As a result, we now expect currency translation to have an adverse impact on full year operating profit of approximately £5m, an increase of £1m over our original expectations, assuming no further change to current rates.

 

The result of weaker margins in our nitrile business and adverse currency translation means that we now expect full year profit before tax to be broadly in-line with the level achieved in 2013.

Enquiries:

 

Adrian Whitfield, Chief Executive OfficerDavid Blackwood, Chief Financial Officer

Tel: 01279 436 211

Pendomer Communications

Charles Armitstead / Rosie Oddy

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.00am (BST) today:

 

Dial-In: +44 203 427 0662.

Please quote "Synthomer" to gain access to the call.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGMNKGKGDZM
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.